LY-3839840
- Generic Name
- LY-3839840
A First-In-Human Study of LY3839840 in Healthy Participants
- First Posted Date
- 2023-12-01
- Last Posted Date
- 2025-03-20
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 178
- Registration Number
- NCT06153355
- Locations
- 🇺🇸
CenExel ACT, Anaheim, California, United States
🇺🇸Fortrea Clinical Research Unit, Madison, Wisconsin, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath